Berkenblit Anna 4
4 · ImmunoGen, Inc. · Filed Feb 11, 2020
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Berkenblit Anna
VP & Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-07$4.55/sh+296,400$1,348,620→ 296,400 totalExercise: $4.55From: 2021-02-07Exp: 2030-02-07→ Common Stock (296,400 underlying)
Footnotes (1)
- [F1]25% of the options are exercisable on the first year anniversary of the grant and the balance is exercisable in twelve equal installments of 6.25%, quarterly over the following three years starting one quarter after the first year anniversary.